Lupin 2023

BD to highlight its deep commitment to drug delivery innovation at Pharmapack

Print Friendly, PDF & Email

FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Co.), a leading global medical technology company, is pleased to be a Premium Partner at Pharmapack 2023 – the European hub for the pharmaceutical packaging and drug delivery device industry – which will take place on February 1-2, 2023 at Paris Expo, Porte de Versailles, in Paris, France.

BD will participate in several educational sessions during the conference sharing insights that build on decades of expertise in partnering with the biopharmaceutical industry to advance drug delivery excellence.

At the event, BD will host two in-person learning labs:

  • “Injection time and usability considerations for self-injection systems, a BD perspective” on February 1 from 15:50 –16:20 presented by Lionel Maritan, Associate Director Program Management.
  • “Introduction to Human Factors Engineering”on February 2 from 10:10 –10:40 presented by Alice Maden, Associate Director Human Factors.

BD will also conduct a workshop on “Enabling digital health solutions with the connected BD UltraSafe Plus™ Passive Needle Guard” on February 1 at 14:20-14:50. This workshop includes information around a new connected version of the BD UltraSafe Plus™ Passive Needle Guard.  Use cases about how this solution may fit into real-life clinical practices will be discussed.  Speakers are Herve Monchoix, Strategic Innovation Leader at BD, Arnaud Guillet, VP Business Development & Commercial Operations at BioCorp and Antoine Millot, Business Developer at Biocorp.

BD is also sponsoring a panel discussion in a conference track on “Innovation of Novel Medicines and Greater Demand for Injectable Home and Self-Administration”.  On February 1 from 14:40 –15:30, this session will bring together industry experts to discuss the trends driving self-administration drug delivery systems and expected practices for developing an injectable combination product.  The keynote introduction to this panel begins at 14:00 and will be presented by Adam Kalbermatten, VP Commercial Development Advanced Drug Delivery Systems from BD.

At the booth, BD will show their wide range of services and solutions to help meet your combination product commercialization needs.  BD experts will be on site to discuss a variety of topics related to the next generation of drug delivery, including:

  • A complete range of services across BD Pharmaceutical Services and Solutions and ZebraSci, a BD company, combination product services to help you achieve your combination product development goals.
  • A broad portfolio of solutions addressing drug delivery needs across various care settings.
  • Prefillable syringe solutions such as: BD Neopak™ Glass Prefillable Syringe for biologic drug delivery and BD Effivax™ Glass Prefillable Syringe for vaccine delivery – our newest innovation for vaccines.
  • Wearable and on-body injectors including BD Libertas™ Wearable Injector* and BD Evolve™ On-body Injector** supporting subcutaneous delivery of biologics, as well as a range of autoinjectors and pens.

Comments are closed.